CCOc1cc2c(cc1OCC)-n1cccc1C(c1cccc(F)c1F)NC2.Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?